Trial Profile
Effect of Lixisenatide on Glucagon Secretion During Hypoglycemia in Patients With Insulin-treated Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 14 Dec 2015 Study design has been changed from double blind to open label.
- 04 Nov 2015 Results published in the Diabetes Care
- 04 Nov 2015 Status changed from active, no longer recruiting to completed, according to results presented in Diabetes Care.